BridgeBio and Partners Unite to Raise Awareness for ATTR-CM Ahead of World Amyloidosis Day

BridgeBio Partners with Communities for ATTR-CM Awareness

In a significant move to enhance cardiovascular health awareness, BridgeBio Pharma Inc. has launched a nationwide educational initiative focusing on transthyretin amyloid cardiomyopathy (ATTR-CM), a heart condition that remains underrecognized despite its potential severity. The effort coincides with World Amyloidosis Day, observed on October 26, and seeks to educate both the public and healthcare professionals about the disease.

On October 6, 2026, a YouTube premiere featuring prominent figures such as Sway Calloway, Howard "H" White, and other medical experts will kick off this campaign. The initiative aims to address the specific cardiovascular health challenges faced by Black Americans, who carry a higher genetic risk for ATTR-CM. As discussed, approximately one in 25 Black Americans carry the associated V142I variant, emphasizing the need for targeted awareness and education.

Understanding ATTR-CM

ATTR-CM occurs when a protein known as transthyretin (TTR) becomes unstable and accumulates in the heart tissue. This buildup can lead to a thickening and hardening of heart muscle, severely impacting the organ's ability to pump blood. The symptoms may closely resemble other, more commonly recognized heart conditions, which often leads to misdiagnosis or delayed treatment. Symptoms such as shortness of breath, fatigue, and even carpal tunnel syndrome might be dismissed as normal aging or attributed to more familiar forms of heart failure.

Howard "H" White, a leading advocate for ATTR-CM awareness who is personally affected by the disease, notes that the conversation surrounding cardiovascular health must include this condition to effectively support those at risk. His journey from experiencing symptoms to receiving a diagnosis underscores the critical need for awareness and discussions between patients and healthcare providers.

Community Engagement

Community partners involved in this campaign include the Association of Black Cardiologists, the National Minority Quality Forum, and 100 Black Men of the Bay Area. Through collaborative efforts, these organizations will host educational events and facilitate viewing opportunities across approximately 40 locations nationwide from major cities like Atlanta, New York, and Los Angeles to Washington D.C.

These community gatherings aim not only to educate but also to empower individuals to recognize symptoms and actively engage in conversations about their health. Through the resources provided, patients and families will be encouraged to ask critical questions and seek appropriate screenings, facilitating earlier recognition of ATTR-CM.

Cultural Relevance and Importance

Led by trusted cultural figures, including Dr. Olajide Williams and Doug E. Fresh from Hip Hop Public Health, the initiative exemplifies an understanding that health conversations thrive when they resonate with individuals’ lives. Dr. Williams emphasizes the goal of translating complex health information into accessible and relatable dialogues that resonate with community values.

This innovative approach not only provides facts about ATTR-CM but also emphasizes the importance of lifestyle elements and cultural context in managing health. The goal is to foster an environment where individuals feel empowered to advocate for their health and that of their families.

Continuing the Conversation

As part of this ongoing effort, resources will be made available through HowardWhiteStory.com, where viewers can find comprehensive information on ATTR-CM, including personal stories and expert advice. The public is encouraged to tune in to the YouTube premiere on October 6 at 6 PM EDT, providing a platform for vital discussions on Black men's heart health and how it intersects with ATTR-CM.

Overall, the collaboration among BridgeBio and its partners marks a significant step toward enhancing awareness and understanding of ATTR-CM within communities at risk. By elevating discussions about this often-overlooked condition, they aim to foster better health outcomes and promote proactive health measures in a population that has historically faced significant cardiovascular health disparities.